Lupeng Pharmaceutical
广州麓鹏制药有限公司
Guangzhou, China · $35.0M raised
- Headquarters
- Guangzhou
- Business Model
- B2B
- Website
- lupengbio.com
- Total Funding
- $35.0M
- Last Round
- $35.0M Venture RoundJan 2024
- Rounds
- 1
About
Chinese biotech developing small-molecule anti-tumor drugs and innovative oncology therapeutics including BTK inhibitors.
Summary
Lupeng Pharmaceutical is a Biotech company based in Guangzhou, China. It has raised $35.0M in total across 1 round, most recently a $35.0M Venture Round round in Jan 2024. Investors include Temasek, Kaitai Capital and Lilly Asia Ventures.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2024
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...